Skip to main content
Beijing Balance Medical Technology Co.,Ltd. logo

Beijing Balance Medical Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 688198 ISIN · CNE100005X15 LEI · 30030099AHB4GS61YJ21 Shanghai Stock Exchange Manufacturing
Filings indexed 569 across all filing types
Latest filing 2026-05-12 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688198

About Beijing Balance Medical Technology Co.,Ltd.

https://balancemed.cn/

Beijing Balance Medical Technology Co., Ltd. specializes in the research, development, and manufacturing of advanced surgical robotic systems. The company is primarily recognized for its Remebot system, a high-precision neurosurgical robot designed to assist surgeons in performing minimally invasive procedures with enhanced accuracy. Its technology integrates medical imaging, surgical planning software, and robotic positioning to facilitate complex brain surgeries, such as biopsies, electrode placements, and aspirations. Beyond neurosurgery, the company has expanded its portfolio to include orthopedic surgical solutions. By focusing on intelligent surgical assistance, Beijing Balance Medical Technology aims to improve clinical outcomes, reduce surgical risks, and standardize complex operative procedures through technological innovation and high-precision engineering.

Recent filings

Filing Released Lang Actions
上海君澜律师事务所关于北京佰仁医疗科技股份有限公司2025年年度股东会的法律意见书
Regulatory Filings Classification · 88% confidence The document is a legal opinion letter (“法律意见书”) issued by a law firm regarding the convening, procedures, qualifications, voting process, and results of the 2025 annual shareholders’ meeting. It does not itself constitute the AGM materials nor a financial report, nor is it a proxy statement or shareholder presentation. Instead, it is a legal attestation/certification letter. Under our rules (CERTIFICATION RULE), such officer or legal attestations should be classified as Regulatory Filings (RNS).
2026-05-12 Chinese
佰仁医疗关于核心技术人员离职的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the departure of a core technical staff member from the company. It details the individual's role, the handover of responsibilities, and the impact on the company. There is no financial data, no discussion of financial results, no mention of regulatory filings like 10-K or interim reports, and no indication of a shareholder meeting or voting results. The document is a corporate announcement about management/staff changes, specifically about a key technical personnel leaving. This fits best under Board/Management Information (MANG), which covers announcements of changes in senior management or key personnel.
2026-05-07 Chinese
佰仁医疗董事会审计委员会2025年度履职情况报告
Audit Report / Information Classification · 95% confidence The document is titled as a "董事会审计委员会2025年度履职情况报告" which translates to "Board Audit Committee 2025 Annual Performance Report." It details the audit committee's activities, meetings, supervision of external auditors, internal audit guidance, review of financial reports, and overall evaluation for the year 2025. The content focuses on the audit committee's duties and oversight rather than presenting full financial statements or detailed audit results. It is a report on the audit committee's performance and oversight activities, which aligns with the category of Audit Report / Information (AR). The document is not an Annual Report (10-K) or Interim Report (IR) as it does not contain comprehensive financial statements or management discussion and analysis. It is also not a Regulatory Filing (RNS) or Report Publication Announcement (RPA) because it contains substantive content rather than just an announcement. Therefore, the best fit is AR (Audit Report / Information). The document length is 2029 characters, which is consistent with a detailed committee report but not a full annual report. FY 2025
2026-04-21 Chinese
佰仁医疗董事会审计委员会对会计师事务所2025年度履行监督职责情况的报告
Audit Report / Information Classification · 95% confidence The document is a report from the Board Audit Committee of Beijing Bairen Medical Technology Co., Ltd. regarding the supervision of the accounting firm for the year 2025. It details the appointment, qualifications, and oversight activities of the accounting firm, including meetings and evaluations related to the audit work. The document is focused on the audit committee's supervisory role and the audit firm's performance rather than presenting the full audit report or financial statements. It is a standalone audit-related report describing the audit committee's oversight and the audit firm's execution of duties, which fits the definition of an Audit Report / Information (AR). The document length is under 5,000 characters and contains substantive content about audit supervision, not merely an announcement or certification, so it is not RPA or RNS. Therefore, the appropriate classification is AR with high confidence. FY 2025
2026-04-21 Chinese
佰仁医疗董事会对独立董事独立性自查情况的专项报告
Regulatory Filings Classification · 95% confidence The document is a special report from the board of directors regarding the self-assessment of the independence of the company's independent directors. It discusses compliance with regulatory requirements about independent directors' independence and the board's evaluation of this self-assessment. There is no financial data, no mention of financial results, no voting results, no management changes, no legal proceedings, or other categories. The document is a regulatory compliance report related to governance but does not fit the Governance Information (CGR) category exactly, as it is a specific report on independent directors' independence. It is not a full Annual Report or Audit Report. Given the nature and length (598 characters), it is best classified as a Regulatory Filing (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2026-04-21 Chinese
北京佰仁医疗科技股份有限公司2025年度审计报告
Regulatory Filings
2026-04-21 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.